Caricamento quotazioni...
Previsioni
Il prezzo obiettivo medio degli analisti è 321,45 € (+13,33%). La mediana è 325,56 € (+14,78%).
| Acquista |
36 |
| Mantieni |
16 |
| Vendi |
0 |
Discussioni nella community
Tradotto (originale in inglese)
Critica il mio portafoglio, 300k Core-Satellite Dividendi-GrowthCiao a tutti, M38 volentieri per un feedback. :)
D Daniel V in Portfolio Roasts
9 9
Notizie Vai al feed delle notizie
Stryker invests about $400 million in CMR Surgical and secures takeover option
Stryker is investing roughly $400 million in CMR Surgical, gaining an option for a full takeover and becoming the exclusive US distributor for the Versius surgical robot. The modular Versius system is FDA‑approved and has already been used in over 40,000 procedures outside the US. Stryker aims to use its reach and sales strength to win market share from Intuitive Surgical; the final takeover price remains undecided, and the investment temporarily reduces balance‑sheet risk through a staged review of the alliance. » Altro su deraktionaer.de
Stryker confirms full‑year targets despite supply bottlenecks for peripheral vascular implants
At the Wells Fargo Healthcare Conference Stryker reaffirmed its 2026 organic growth forecast of 8.3–9.3%, but said it is being weighed down by aftereffects of a cyber incident, production bottlenecks for peripheral vascular implants and weaker demand for hip implants. Supply constraints are expected to shave about 70–80 basis points off growth in each of Q2–Q4; the cyber incident could cost around $350 million in 2026. At the same time, Stryker reported strong order intake for capital equipment and solid growth in trauma and extremities, expects a recovery in 2027 once supply issues are resolved, and continues to rely on M&A, its product pipeline and the Mako platform. A detailed update is planned with the Q3 results. » Altro su de.investing.com
Supply chain problems weigh on Stryker — stock falls 7.7%
At the Wells Fargo Healthcare Conference, Stryker reported ongoing production problems that are limiting inventory availability and hindering new business opportunities. CFO Preston Wells said the issue will extend into the third quarter and partly into the fourth. The joint-replacement division showed a weaker-than-expected recovery due to stronger seasonality; competitor Zimmer Biomet also declined. » Altro su de.investing.com
Stryker shares fall after narrowed full-year guidance
Stryker reported adjusted EPS of $3.69 for Q2 2026 (expectation $3.49) and revenue of about $6.6 billion (+9.4%), largely in line with consensus expectations. However, the outlook for 2026 was narrowed: organic net sales growth is expected at 8.3–9.3% and adjusted EPS at $14.95–15.10. The stock fell about 8.4% in after-hours trading, as the tighter guidance range limits upside and investors reassess the recovery momentum after the prior period was weighed down by a cyberattack. » Altro su de.investing.com
Stryker launches US market rollout of handheld robotic system Mako RPS
Stryker has announced the commercial launch of the handheld robotic system Mako RPS for total knee arthroplasty in the US. The system expands the Mako portfolio with a handheld platform featuring a robot-assisted saw and active adjustment technology, and is compatible with the Triathlon total knee arthroplasty system as well as the Q Guidance System. Stryker notes strong customer response from the limited launch; Mako technology has already been used in more than 2.5 million procedures across 47 countries. » Altro su de.investing.com
Dividendi storici Dividendi
Tutte le metriche sui dividendi Tutte le metricheDati finanziari dell'azienda
| (EUR) | settembre 2026 | YoY |
|---|---|---|
| Ricavi | 5,76 Mld | 11,52% |
| Utile lordo | 3,75 Mld | 14,26% |
| Utile netto | 664,79 Mln | 9,18% |
| EBITDA | 1,14 Mld | 1,79% |
Dati fondamentali
| Metrica | Valore |
|---|---|
Capitalizzazione di mercato | 107,43 Mld € |
Numero di azioni | 380,69 Mln |
Massimo/minimo a 52 settimane | 353,07 € - 242,13 € |
Rendimento da dividendo | 1,09% |
Dividendi TTM | 3,04 € |
Beta | 0,78 |
Rapporto P/E | 32,93 |
Rapporto PEG | 1,46 |
Rapporto P/B | 5,07 |
Rapporto P/S | 4,50 |
Profilo aziendale
Stryker Corporation opera come società di tecnologia medica. L'azienda opera attraverso due segmenti, MedSurg e Neurotechnology, e Orthopaedics and Spine. Il segmento Orthopaedics and Spine fornisce impianti per l'uso in protesi d'anca e di ginocchio, nonché in interventi di traumatologia e chirurgia degli arti. Questo segmento offre anche prodotti per impianti spinali composti da sistemi cervicali, toracolombari e intersomatici, utilizzati in terapie per lesioni spinali, deformità e patologie degenerative. Il segmento MedSurg and Neurotechnology offre apparecchiature chirurgiche e sistemi di navigazione chirurgica, sistemi endoscopici e di comunicazione, dispositivi per la movimentazione dei pazienti, apparecchiature di emergenza medica e prodotti monouso per la terapia intensiva, dispositivi medici rigenerati e rimanufatturati, nonché altri prodotti medicali utilizzati in diverse specialità mediche. Questo segmento fornisce inoltre prodotti di neurotecnologia, tra cui prodotti utilizzati per tecniche endovascolari mini-invasive; prodotti per interventi chirurgici al cervello e alla base cranica; prodotti ortobiologici e di biochirurgia, come innesti ossei sintetici e prodotti di vertebroplastica e cifoplastica; prodotti mini-invasivi per il trattamento dell'ictus ischemico e emorragico acuto; e impianti craniomaxillofacciali, inclusi dispositivi cranici, maxillofacciali e per la parete toracica, nonché sostituti durali e sigillanti. L'azienda vende i propri prodotti a medici, ospedali e altre strutture sanitarie tramite filiali e succursali di proprietà, nonché tramite rivenditori e distributori terzi in circa 75 paesi. Stryker Corporation è stata fondata nel 1941 ed ha sede a Kalamazoo, nel Michigan.
| Nome | Stryker |
| CEO | Kevin A. Lobo |
| Sede centrale | Portage,
mi Stati Uniti |
| Sito web | |
| Settore | Sanità |
| Industria | Tecnologia sanitaria |
| Quotazione in borsa | 17/03/1980 |
| Dipendenti | 56.000 |
Simboli di borsa
| Borsa | Simbolo |
|---|---|
NYSE | SYK |
London Stock Exchange | 0R2S.L |
Frankfurt | SYK.F |
Düsseldorf | SYK.DU |
Milan | 1SYK.MI |
London | 0R2S.L |
SIX | SYK.SW |
München | SYK.MU |
Wien | SYK.VI |